These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38972365)

  • 21. Synergistic cranberry juice combinations with natural-borne antimicrobials for the eradication of uropathogenic Escherichia coli biofilm within a short time.
    Kim HW; Chung DH; Kim SA; Rhee MS
    Lett Appl Microbiol; 2019 Apr; 68(4):321-328. PubMed ID: 30801748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic Resistance Among Uropathogenic
    Kot B
    Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection.
    González MJ; Robino L; Iribarnegaray V; Zunino P; Scavone P
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28505288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.
    Yazdi M; Bouzari M; Ghaemi EA
    J Mol Microbiol Biotechnol; 2018; 28(1):37-46. PubMed ID: 29617701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
    Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
    J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
    Zalewska-Piątek BM; Piątek RJ
    Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.
    Alshaikh SA; El-Banna T; Sonbol F; Farghali MH
    Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):20. PubMed ID: 38402146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis of silver nanoparticles by Fusarium scirpi and its potential as antimicrobial agent against uropathogenic Escherichia coli biofilms.
    Rodríguez-Serrano C; Guzmán-Moreno J; Ángeles-Chávez C; Rodríguez-González V; Ortega-Sigala JJ; Ramírez-Santoyo RM; Vidales-Rodríguez LE
    PLoS One; 2020; 15(3):e0230275. PubMed ID: 32163495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
    Mittal S; Sharma M; Chaudhary U
    Pathog Glob Health; 2015 Feb; 109(1):26-9. PubMed ID: 25605466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Previous Antibiotic Exposure Reshapes the Population Structure of Infecting Uropathogenic Escherichia coli Strains by Selecting for Antibiotic Resistance over Urovirulence.
    Ballash GA; Diaz-Campos D; van Balen JC; Mollenkopf DF; Wittum TE
    Microbiol Spectr; 2023 Aug; 11(4):e0524222. PubMed ID: 37338386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
    Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
    Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive expression analysis of pathogenicity genes in uropathogenic Escherichia coli strains.
    Paniagua-Contreras GL; Hernández-Jaimes T; Monroy-Pérez E; Vaca-Paniagua F; Díaz-Velásquez C; Uribe-García A; Vaca S
    Microb Pathog; 2017 Feb; 103():1-7. PubMed ID: 27993701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
    Shah C; Baral R; Bartaula B; Shrestha LB
    BMC Microbiol; 2019 Sep; 19(1):204. PubMed ID: 31477018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of two novel Escherichia bacteriophages against multiple drug resistant avian pathogenic Escherichia coli.
    Karami M; Goudarztalejerdi A; Mohammadzadeh A; Berizi E
    BMC Infect Dis; 2024 May; 24(1):497. PubMed ID: 38755537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic
    Kadry AA; Al-Kashef NM; El-Ganiny AM
    Afr Health Sci; 2020 Mar; 20(1):238-247. PubMed ID: 33402912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.